About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Liquid Biopsy Collection Study | Clinical Trials | Clareo Health

Back to clinical trial search

Active Not RecruitingNCT06068348

Liquid Biopsy Collection Study

The purpose of this study is to develop a liquid biopsy approach for detection of circulating tumor cells (CTC) that could be used in place of the more invasive and potentially risky methods of tissue...

Lead sponsor: University of Central Florida•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

University of Central Florida

Age

18 - 80 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Male or female
•Age greater than or equal to 18 and less than or equal to 80 years.

Exclusion Criteria

•Adults unable to give informed consent
•Individuals who are not yet adults (infants, children, teenagers; under the age of 18)
•Individuals who weigh less than 110 lbs (as standard clinically advised to not give blood)
•Pregnant women (due to hormonal changes in blood)
•Prisoners
•Persons reporting a current microbial (bacterial, viral, or fungal) infections
•Persons reporting that they are current taking antibiotic medications
•Persons with body temperatures above 99oF (indicating a fever)

Related studies

The Effect of Mobilising Patients Using Nature Sounds on Anxiety, Pain and Stress Levels

NCT06848777 · Anxiety, Pain, and more

Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer

NCT01015625 · Synchronous Metastasized Breast Cancer, Circulating Tumor Cells

COMPLETEDEARLY Phase 1

Digoxin Induced Dissolution of CTC Clusters

NCT03928210 · Breast Cancer, Circulating Tumor Cells (CTCs)

Significance of Circulating Tumor Cells in the Treatment of Gastric and Rectal Cancer

NCT02955173 · Circulating Tumor Cells, Colorectal Cancer, and more

Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer

NCT02499458 · Clear Cell Renal Cancer, Circulating Tumor Cells, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 6, 2024Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

Phase—

Enrollment60

Start dateOct 2021

Last updatedDec 6, 2024

Condition

Chaperonin-Containing TCP-1 Circulating Tumor Cells CCT CTC

Locations shown

University of Central Florida

Orlando, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 6, 2024Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions